Dose-dense cisplatin/paclitaxel: a well-tolerated and highly effective chemotherapeutic regimen in patients with advanced ovarian cancer

Research output: Contribution to journal › Article › Academic › peer-review

39 Citations (Scopus)

Research programs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{0c8627bb78764b868c36037dd866b5d4,

title = "Dose-dense cisplatin/paclitaxel: a well-tolerated and highly effective chemotherapeutic regimen in patients with advanced ovarian cancer",

author = "FE Jongh and \{de Wit\}, Ronald and Jaap Verweij and A Sparreboom and \{van den Bent\}, Martin and Gerrit Stoter and MEL Burg",

year = "2002",

doi = "10.1016/S0959-8049(02)00242-3",

language = "Undefined/Unknown",

volume = "38",

pages = "2005--2013",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

TY - JOUR

T1 - Dose-dense cisplatin/paclitaxel: a well-tolerated and highly effective chemotherapeutic regimen in patients with advanced ovarian cancer

AU - Jongh, FE

AU - de Wit, Ronald

AU - Verweij, Jaap

AU - Sparreboom, A

AU - van den Bent, Martin

AU - Stoter, Gerrit

AU - Burg, MEL

PY - 2002

Y1 - 2002

U2 - 10.1016/S0959-8049(02)00242-3

DO - 10.1016/S0959-8049(02)00242-3

M3 - Article

SN - 0959-8049

VL - 38

SP - 2005

EP - 2013

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -